LRRK2 and Parkinson disease: These include the transfer of mutated leucine-rich repeat kinase 2 (LRRK2) linked to late-onset PD, which can interact with Rab proteins, co-localize with multi-vesicular bodies (MVBs) [49], and get released into the extracellular milieu through EVs [50-52].